Skip to main content

Judd Wendell Moul, MD

James H. Semans, M.D. Professor of Urologic Surgery, in the School of Medicine
Professor of Surgery
Professor in Anesthesiology
Office: 1573 White Zone, Duke South, Durham, NC 27710
Campus Mail: DUMC Box 3707 Med Ctr, Durham, NC 27710

Dr Judd Moul joined the Duke faculty in mid 2004 after a career in the US Army Medical Corps mainly at Walter Reed Army Medical Center.  He is a retired colonel and a noted researcher and clinician in the area of prostate cancer and is a urologic oncologist. He served as the division chief of Duke Division of Urology from 2004 to 2011 and was named the James H Semans MD Professor of surgery in 2009 becoming Duke's first named endowed chair for urology.  He was awarded the Gold Cystoscope Award from the American Urologic Association as well as Castle Connelly Physician of the year for Clinical Medicine in 2009.  He has performed more than 1300 radical prostatectomies since joining the Duke faculty and is committed to outcomes research on this series and in other areas of prostate cancer.  He served as the Editor for Prostate Cancer and Prostatic Dissease, a Nature Medicine journal, for more than a decade and is a popular speaker and lecturer having been visiting professor and keynote speaker throughout the US and the World.  He is very committed to training residents and mentoring students and trainees. 

Education and Training

  • Fellowship, Urologic Oncology, Duke University, 1988 - 1989
  • Residency, Urology, Walter Reed Army Medical Center, 1983 - 1987
  • Residency, Surgery, Walter Reed Army Medical Center, 1982 - 1983
  • M.D., Thomas Jefferson University, 1982
  • B.S., Pennsylvania State University, 1979

Publications

Sutton, S Scott, E David Crawford, Judd W. Moul, James W. Hardin, and Eric Kruep. “Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System..” World J Urol 34, no. 8 (August 2016): 1107–13. https://doi.org/10.1007/s00345-015-1754-6.

Full Text

Lynch, Henry T., Omofolasade Kosoko-Lasaki, Stephen W. Leslie, Marc Rendell, Trudy Shaw, Carrie Snyder, Anthony V. D’Amico, et al. “Screening for familial and hereditary prostate cancer..” Int J Cancer 138, no. 11 (June 1, 2016): 2579–91. https://doi.org/10.1002/ijc.29949.

Full Text

Armstrong, A. J., S. Halabi, P. Healy, W. R. Lee, B. F. Koontz, J. W. Moul, K. Mundy, et al. “A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy..” In Prostate Cancer Prostatic Dis, 19:100–106, 2016. https://doi.org/10.1038/pcan.2015.59.

Full Text

Scardino, Peter T., Jack M. Cuzick, Steve Stone, Brent Evans, Matthew R. Jorgensen, James Andrew Eastham, Thomas E. Keane, et al. “Application of active surveillance threshold to series of samples submitted for commercial testing..” In Journal of Clinical Oncology, 34:84–84. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.84.

Full Text

Tay, Kae Jack, Rajan T. Gupta, Ardeshir R. Rastinehad, Efrat Tsivian, Stephen J. Freedland, Judd W. Moul, and Thomas J. Polascik. “Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls..” Expert Rev Anticancer Ther 16, no. 3 (2016): 303–11. https://doi.org/10.1586/14737140.2016.1131155.

Full Text

Pages